Cargando…
Development an Immune-Related MicroRNA Risk Index in Hepatocellular Carcinoma
PURPOSE: Hepatocellular carcinoma (HC) has emerged as one of the most prevalent malignancies on a global scale. Recently, immunotherapy has achieved favorable effectiveness in the management of multiple cancers. However, there are limited therapeutic options for advanced HC. As the liver is a specia...
Autores principales: | Zhou, Shun, Xu, Jian, Wang, Dong, Wang, Yong, Meng, Lijuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019458/ https://www.ncbi.nlm.nih.gov/pubmed/35466321 http://dx.doi.org/10.1155/2022/5224434 |
Ejemplares similares
-
Development of MicroRNA Therapeutics for Hepatocellular Carcinoma
por: Aravalli, Rajagopal N.
Publicado: (2013) -
Progress of HOTAIR-microRNA in hepatocellular carcinoma
por: Wang, Bing-rong, et al.
Publicado: (2022) -
Expression of Serum Exosomal MicroRNA-21 in Human Hepatocellular Carcinoma
por: Wang, Hongwei, et al.
Publicado: (2014) -
Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma
por: Zhang, Zhu-qing, et al.
Publicado: (2014) -
MicroRNA involvement in hepatocellular carcinoma
por: Gramantieri, Laura, et al.
Publicado: (2008)